Owens & Minor, Inc.
5.22-0.06 (-1.14%)
Oct 29, 4:00:02 PM EDT · NYSE · OMI · USD
Key Stats
Market Cap
403.21MP/E (TTM)
-Basic EPS (TTM)
-5.61Dividend Yield
0%Recent Filings
8-K
CIO resigns for new role
Owens & Minor's Executive Vice President and Chief Information Officer, Snehashish Sarkar, resigned effective September 26, 2025, to join another company after serving since October 2022. He leaves behind a robust global IT team primed to sustain the firm's strategic goals. The departure disrupts continuity in tech leadership. Yet the team stands ready.
10-Q
Q2 FY2025 results
Owens & Minor's continuing operations posted net revenue of $681.9M for Q2 FY2025 ended June 30, 2025, up 3.3% y/y from $660.4M, fueled by gains in sleep therapy (up 6.7%), ostomy (up 10.3%), and urology (up 11.9%), though diabetes dipped 1.7% amid supplier disruptions and pharmacy shifts. Gross margin held steady at 47.6%, but operating loss widened to $39.7M from $16.9M income y/y, hammered by an $80M Rotech termination fee and $18M financing costs, while SG&A edged down 0.8% on efficiencies. Diluted EPS from continuing operations fell to ($1.09) from ($0.09), consistent with 76.9M weighted shares. Cash climbed to $38.3M, with $286M revolver availability and total debt at $1.98B; free cash flow not disclosed in the 10-Q. The P&HS segment sale process advances, eyeing deleveraging. Yet contract terminations from a major payor loom as a key risk.
8-K
Q2 results amid segment sale
Owens & Minor classified its Products & Healthcare Services segment as discontinued operations amid a likely sale, sharpening focus on the growing Patient Direct business. Q2 continuing operations revenue climbed to $681.9 million from $660.4 million last year, with adjusted EBITDA up to $96.6 million, yet GAAP losses swelled to $83.8 million due to an $80 million Rotech deal breakage fee. The company eyes $2.76-$2.82 billion full-year revenue. Sale completion remains uncertain.
8-K
Merger terminated, notes redeemed
Owens & Minor terminated its merger agreement to acquire Rotech Healthcare Holdings on June 5, 2025, scrapping the planned deal announced last July. This triggers a mandatory redemption of its $1,000,000,000 10% senior secured notes due 2030, set for June 10 at full principal plus accrued interest. The move clears acquisition hurdles but demands swift debt repayment. Risks loom from financing pressures amid economic uncertainties.
8-K
Merger termination announced
Owens & Minor mutually terminated its merger agreement to acquire Rotech Healthcare on June 3, 2025, paying an $80 million termination fee on June 5. The deal collapsed due to unviable regulatory hurdles with the FTC, despite potential benefits for patients and providers. OMI will redeem $1 billion in notes and cancel related financing. Deal off. Now, focus shifts to organic growth in home-based care and deleveraging via cash flow.
IPO
Website
Employees
Sector
Industry
AHCO
AdaptHealth Corp.
9.17-0.30
CAH
Cardinal Health, Inc.
164.47+1.68
COR
Cencora, Inc.
333.17-2.47
EBOSF
EBOS GROUP
23.75+0.00
HCSG
Healthcare Services Group, Inc.
18.81-0.42
MCK
McKesson Corporation
807.63+3.04
MDXG
MiMedx Group, Inc
7.19+0.31
OMCL
Omnicell, Inc.
29.57-0.37
RMD
ResMed Inc.
253.62-2.95
SOLV
Solventum Corporation
69.78-1.14